Showing 34,984 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

IAS 2025: HIV funding crisis the focus of IAS 2025, 16 July 2025

July 2025
Finance & funding

“We will not go back!”: a powerful, resolute response to funding cuts at IAS 2025

News
16 July 2025
Government, leadership & policy

Rwanda’s HIV leadership on display at IAS 2025

News
16 July 2025
Global health initiatives

Global AIDS funding to be pulled from Trump clawbacks request

Editor's pick
POLITICO
15 July 2025
Injectable & long-acting HIV treatment

ViiV Healthcare and Medicines Patent Pool extend voluntary licensing agreement to enable access to long-acting injectable HIV treatment

Editor's pick
Medicines Patent Pool
15 July 2025
HIV treatment

How treatment works Illustrated

About HIV
July 2025
Access to healthcare

Dutch survey finds informal use of doxyPEP is rising

Editor's pick
CIDRAP
10 July 2025
Pharmaceutical industry

HIV drugmaker Theratechnologies agrees to $254M buyout by CDMO Future Pak

Editor's pick
FiercePharma
10 July 2025
Conference announcements & declarations

IAS 2025 Preview: Amidst a Worldwide Funding Emergency, HIV Science Moves Forward

Editor's pick
TheBodyPro
10 July 2025
PEP

2025 Updates to US HIV nPEP Guidelines: Many Welcome Changes—and One Concern

Editor's pick
TheBodyPro
10 July 2025
Cardiovascular disease

Popular HIV Drug Linked to Higher Risk for MACE

Editor's pick
Medscape (requires free registration)
10 July 2025
Injectable & long-acting PrEP

Global Fund Secures Access to Breakthrough HIV Prevention Drug Lenacapavir for Low- and Middle-Income Countries

Editor's pick
Global Fund News Releases
10 July 2025
Injectable & long-acting PrEP

Gilead to provide HIV prevention drug to 2 million people in lower-income countries at cost

Editor's pick
STAT (requires free registration)
10 July 2025
Cancer

Did Having HIV Increase the Risk of Heywood’s Cancer?

Editor's pick
My Fabulous Disease
10 July 2025
Government, leadership & policy

South Africans fear spike in HIV infections as US aid cuts bite

Editor's pick
BBC News
10 July 2025
Epidemiology

Millions at Risk of HIV Infection and Death After US Funding Cuts, Warns UNAIDS

Editor's pick
Health Policy Watch
10 July 2025
New & experimental HIV treatments

U.S. FDA Accepts New Drug Application for Merck’s Doravirine/Islatravir, an Investigational, Once-Daily, Oral, Two-Drug Regimen for Treatment of Adults with Virologically Suppressed HIV-1 Infection

Editor's pick
Merck press release
10 July 2025
Finance & funding

South Africa: Treasury hands HIV response a lifeline, but it’s probably too little

Editor's pick
GroundUp News
10 July 2025
Global health initiatives

Global Fund plans to cut $1.4 billion from grants it has already awarded

Editor's pick
Devex (requires free registration)
10 July 2025
Global health initiatives

Board agrees for UNAIDS to use its reserves for restructuring

Editor's pick
Devex (requires free registration)
10 July 2025
Conference announcements & declarations

Coming soon: news from IAS 2025

News
7 July 2025
Global health initiatives

UNAids chief ‘shaken and disgusted’ by US cuts that will mean millions more deaths

Editor's pick
The Guardian
7 July 2025
Healthy living

Eight ways to look after your health Illustrated

About HIV
July 2025
Healthy living

A healthy weight Illustrated

About HIV
July 2025